US 12234294
Pharmaceutical composition of a humanized anti-CD40 antibody
granted A61KA61K39/39591A61K47/183
Quick answer
US patent 12234294 (Pharmaceutical composition of a humanized anti-CD40 antibody) held by Kiniksa Pharmaceuticals, GmbH expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kiniksa Pharmaceuticals, GmbH
- Grant date
- Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K39/39591, A61K47/183, A61K9/0019